Mr (or Ms) Lockstock - yes you are right: both that I did know...

Mr (or Ms) Lockstock - yes you are right: both that I did know it - and - that it is good of you to point it out for the reason you say. Thanks for highlighting it. I meant only the B cell suite.

(Just typing that makes me want a few more - the oncolytic virus could well eclipse it all and I also tend to forget about it a bit. The Vaxinia acquisition is like HER VAXX was when I first signed on: hopeful in models, yet to validate in people and something that the market seems to be assigning no value to.

Last little comment - what I have loved about how IMU has acquired it's extra lines is it's not been cash buying. IMU has 'merged tech': meaning IMU has faith in what it's acquiring and those selling have faith in what IMU had pre-merger. Sellers do not usually sell things for less than what they think they are worth - so I'm always wary of cash acquisitions.

Anyways, thanks Lockstock and go IMU!!